EX-10.1 2 f10q0619ex10-1_rubicon.htm ASSET PURCHASE AGREEMENT FOR DIRECT DOSE RX EXECUTION VERSION ASSET PURCHASE AGREEMENTAsset Purchase Agreement • May 5th, 2020 • Delaware
Contract Type FiledMay 5th, 2020 JurisdictionThis Asset Purchase Agreement (this “Agreement”), dated as of May 17, 2019, is entered into by and among Wellfount, Corporation, a Delaware corporation (“Seller”), Rubicon DTP LLC, a Delaware limited liability company (“Buyer”) and, for the purposes of Section 2.5, Section 5.1 and Article VI only, Rubicon Technology, Inc., a Delaware corporation (“Rubicon”).
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • August 14th, 2019 • Rubicon Technology, Inc. • Semiconductors & related devices • Delaware
Contract Type FiledAugust 14th, 2019 Company Industry JurisdictionThis Trademark Assignment (this “Trademark Assignment”) is effective as of May ___, 2019 and is between Wellfount, Corporation, a Delaware corporation (the “Assignor”) and Rubicon DTP, LLC, a Delaware limited liability company (the “Assignee”).